Bristol-Myers Squibb (BMY) Responded to Starboard's Letter, Confident in Combination with Celgene (CELG)

February 28, 2019 12:00 PM
Bristol-Myers Squibb Company (NYSE: BMY) today issued the following statement in response to a letter from Starboard Value: Bristol-Myers Squibb ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News Hedge Funds Management Comments Mergers and Acquisitions

Next Articles